Results for tag: "Exocrine Pancreatic Insufficiency Drug"

Exocrine Pancreatic Insufficiency (EPI) Drug is a type of Endocrine and Metabolic Disorders Drugs. It is used to treat a condition in which the pancreas does not produce enough digestive enzymes. These drugs are used to replace the enzymes that are not produced by the pancreas, allowing the body to digest food properly. They are available in both oral and injectable forms. Common side effects include abdominal pain, nausea, and diarrhea. EPI Drugs are used to treat a variety of conditions, including cystic fibrosis, chronic pancreatitis, and pancreatic cancer. They are also used to treat malabsorption syndromes, such as celiac disease and Crohn's disease. The market for EPI Drugs is growing due to the increasing prevalence of these conditions. Some companies in the EPI Drug market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more